Free Trial

Hoth Therapeutics (HOTH) News Today

Hoth Therapeutics logo
$0.87 -0.02 (-1.88%)
As of 03:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Hoth Therapeutics’ HT-001 shows efficacy in Phase 2a pruritus trial
Hoth Flat on Hookup with Washington Univ.
Hoth Dips on Drug Application
Hoth Therapeutics to submit Expanded Access application for HT-001
Hoth Therapeutics announces collaboration with OnTargetx R&D
Hoth Therapeutics regains compliance with Nasdaq listing rules
Hoth Therapeutics Restores Compliance With Nasdaq Listing Requirements
Hoth Therapeutics Expands IP Portfolio With New Patent Applications
Hoth Therapeutics: Strong balance sheet includes over $10M cash, no debt
Hoth Therapeutics responds to market rumors, says no plans for offering
Get Hoth Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter.

HOTH Media Mentions By Week

HOTH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HOTH
News Sentiment

0.50

0.72

Average
Medical
News Sentiment

HOTH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HOTH Articles
This Week

2

1

HOTH Articles
Average Week

Get Hoth Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:HOTH) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners